Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase

Despite numerous discoveries from genetically engineered mice, relatively few have been translated to the bedside, mainly because it is difficult to translate from genes to drugs. This investigation examines an antiviral drug, which also has an action to selectively inhibit type 5 adenylyl cyclase (...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Iwatsubo, Kosaku, Bravo, Claudio, Uechi, Masami, Baljinnyam, Erdene, Nakamura, Takashi, Umemura, Masanari, Lai, Lo, Gao, Shumin, Yan, Lin, Zhao, Xin, Park, Misun, Qiu, Hongyu, Okumura, Satoshi, Iwatsubo, Mizuka, Vatner, Dorothy E., Vatner, Stephen F., Ishikawa, Yoshihiro
פורמט: Artigo
שפה:Inglês
יצא לאור: American Physiological Society 2012
נושאים:
Integrative Cardiovascular Physiology and Pathophysiology
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3378263/
https://ncbi.nlm.nih.gov/pubmed/22505646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00190.2012
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים